China GMP
Form: tablet
Strength: 20mg, 50mg
Indication: Non-small Cell Lung Cancer and Metastatic Colorectal Cancer.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>This product belongs to the <strong>oral small-molecule kinase inhibitor</strong> category, manufactured under strict <strong>GMP standards</strong>. It typically features a specialized capsule formulation designed for precise dosage delivery and chemical stability during storage.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Research:</strong> Used in clinical trials for targeting specific tyrosine kinases.</li>
<li><strong>Pharmaceutical Distribution:</strong> Sourced by hospitals and clinics for targeted cancer therapies.</li>
<li><strong>Bulk Manufacturing:</strong> Procured by generic drug producers for repackaging and supply chain distribution.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Safety Handling:</strong> Requires PPE to prevent direct contact with active pharmaceutical ingredients.</li>
<li><strong>Storage Conditions:</strong> Must be kept in controlled environments to maintain potency.</li>
<li><strong>Replacement Cycle:</strong> Adhere strictly to manufacturer expiration dates to ensure therapeutic efficacy.</li>
</ul>